Perspectives of Opportunities and Barriers: Department of Corrections Extended-Release Naltrexone Program Evaluation

People involved in the criminal justice system have higher rates of opioid use disorder (OUD) and are less likely to receive recovery services. Medications to treat OUD, such as extended-release naltrexone, have been found to reduce relapse and recidivism. We hope to provide practical lessons learned from the evaluation process of the Department of Corrections' Extended-Release Naltrexone Program and considerations for incorporating medications to treat OUD into a reentry program. The program evaluation followed participants for 1 year and conducted interviews and surveys on health, well-being, and community reintegration. The program experienced significant barriers to effective implementation; few participants received extended-release naltrexone after release, and no case management was provided after release. Despite barriers to implementation, participants reported the need for medications to support treatment of OUD. Results of this program evaluation reveal barriers and opportunities to inform longer-term strategies for similar programs, including considerations for programs pre- and postrelease, participant follow-up, and treatment options. In addition, the lack of reentry planning and coordination between the correctional system and the community introduced barriers. Opportunities exist for holistic supportive reentry starting with needs identification and coordination among correctional facilities, discharge planners, and community providers.